Posterior Uveitis Pipeline Report H1 2016 - Review of 8 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Posterior Uveitis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Posterior Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Posterior Uveitis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Posterior Uveitis Overview
  3. Therapeutics Development
  4. Pipeline Products for Posterior Uveitis - Overview
  5. Pipeline Products for Posterior Uveitis - Comparative Analysis
  6. Posterior Uveitis - Therapeutics under Development by Companies
  7. Posterior Uveitis - Therapeutics under Investigation by Universities/Institutes
  8. Posterior Uveitis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Posterior Uveitis - Products under Development by Companies
  13. Posterior Uveitis - Products under Investigation by Universities/Institutes
  14. Posterior Uveitis - Companies Involved in Therapeutics Development
  • Aciont Inc.
  • Neuroptis Biotech
  • Oculis ehf
  • pSivida Corp.
  • Regeneron Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • ThromboGenics NV
  • Virogenomics BioDevelopment, Inc.

For more information visit http://www.researchandmarkets.com/research/4973lw/posterior_uveitis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs, Optical

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs, Optical